Single-Dose Prophylaxis Matches 12-Dose Courses in Elective Urological Surgery, Without Proven Equivalence
This randomized trial across mixed elective urological procedures in India gives stewardship pharmacists pragmatic support for single-dose prophylaxis, while the absence of a prespecified margin limits how firmly equivalence can be claimed.
📅 Journal publication: Nov 2026(online Oct 29, 2026)·Last updated: Nov 9, 2026
Extended antibiotic prophylaxis shows no added benefit in urological surgery.
Prolonged antibiotic use in surgical prophylaxis can contribute to resistance without additional benefits, necessitating reevaluation of protocols. The study found a 30-day symptomatic urinary tract infection rate of 7.1% for single-dose versus 5.5% for extended prophylaxis, with no significant difference (p = 0.536). This suggests that extended antibiotic prophylaxis may not provide added benefit for preventing postoperative infections in elective urological surgery, supporting stewardship efforts. Single-dose prophylaxis may suffice for elective urological surgeries, reducing unnecessary antibiotic use.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Free account, no credit card. Includes 1 full deep analysis every month.
Authors:Nayyar R, Shetty RS, Kushwaha A, Mahapatra S, Panaiyadiyan S, Singh P, Jain S, Kumar M, Kumar S, Nayak B, Seth A
Citation:Nayyar R, Shetty RS, Kushwaha A, et al. Single-dose/day versus extended antibiotic prophylaxis for elective urological surgery: a prospective randomized controlled trial. EClinicalMedicine. 2026;101:104303. doi:10.1016/j.eclinm.2026.104303